Xiuli Zhang

Dr. Xiuli Zhang

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
XZXiuli Zhang
Xiuli Zhang
HHHui He
Hui He
DLDan Liang
Dan Liang
XZXiuli Zhang
Xiuli Zhang
WLWei Liang
Wei Liang
JMJianfei Ma
Jianfei Ma
Diabetic nephropathy (DN) is a serious diabetic complication with renal hypertrophy and expansion of extracellular matrices in renal fibrosis. Epithelial-to-mesenchymal transition (EMT) of renal tubular epithelial cells may be involved in the main mechanism. Berberine (BBR) has been shown to have antifibrotic effects in liver, kidney and lung. However, the mechanism of cytoprotective effects of BBR in DN is still unclear. In this study, we investigated the curative effects of BBR on tubulointerstitial fibrosis in streptozotocin (STZ)-induced diabetic mice and the high glucose (HG)-induced EMT in NRK 52E cells. We found that BBR treatment attenuated renal fibrosis by activating the nuclear factor-erythroid 2-related factor 2 (Nrf2) signaling pathway in the diabetic kidneys. Further revealed that BBR abrogated HG-induced EMT and oxidative stress in relation not only with the activation of Nrf2 and two Nrf2-targeted antioxidative genes (NQO-1 and HO-1), but also with the suppressing the activation of TGF-β/Smad signaling pathway. Importantly, knockdown Nrf2 with siRNA not only abolished the BBR-induced expression of HO-1 and NQO-1 but also removed the inhibitory effect of BBR on HG-induced activation of TGF-β/Smad signaling as well as the anti-fibrosis effects. The data from present study suggest that BBR can ameliorate tubulointerstitial fibrosis in DN by activating Nrf2 pathway and inhibiting TGF-β/Smad/EMT signaling activity.

4 March 2014 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
XZXiuli Zhang
Xiuli Zhang
YZYue Zhao
Yue Zhao
QCQingqing Chu
Qingqing Chu
ZWZhan-You Wang
Zhan-You Wang
HLHongjuan Li
Hongjuan Li
ZCZhi-Hong Chi
Zhi-Hong Chi

17 July 2020 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
XZXiuli Zhang
Xiuli Zhang
TGTingwen Guan
Tingwen Guan
BYBoxuan Yang
Boxuan Yang
Harvest F. GuHarvest F. Gu
Harvest F. Gu
ZCZhihong Chi
Zhihong Chi
Zinc transporter 8 (ZnT8) transports zinc ions for crystallization and storage of insulin in pancreatic beta-cells and ZnT8 dysfunction is involved in pathogenesis of diabetes. The current study aimed to investigate whether ZnT8 has effects in pathophysiology of diabetic kidney disease (DKD) by using animal models for diabetes, including STZ-induced diabetic, db/db, ZnT8-KO, ZnT8-KO-STZ and ZnT8-KO-db/db mice. Results demonstrated that urine albumin to creatinine ratio and epithelial-to-mesenchymal transition (EMT) were increased in kidneys of ZnT8-KO-STZ and ZnT8-KO-db/db mice compared with C57BL/6 J and ZnT8-KO mice, while serum TGF-β1, IL-6, and TNF-α levels were elevated in parallel. In kidneys of mice intercrossed between ZnT8-KO and STZ-induced diabetic or db/db mice, these three inflammatory factors, ACR and EMT were also found to be increased compared with C57BL/6J, db/db and ZnT8-KO mice. Furthermore, ZnT8 up-regulation by hZnT8-EGFP reduced the levels of high glucose (HG)-induced EMT and inflammatory factors in normal rat kidney tubular epithelial cell (NRK-52E cells). Expression of phosphorylated Smad2/Smad3 was up-regulated after HG stimulation and further enhanced by ZnT8 siRNA but down-regulated after hZnT8-EGFP gene transfection. The current study thus provides the first evidence that ZnT8 protects against EMT-tubulointerstitial fibrosis though the restrain of TGF-β1/Smads signaling activation in DKD.

15 June 2020 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
XZXiuli Zhang
Xiuli Zhang
NSNorhashimah Abu Seman
Norhashimah Abu Seman
Henrik FalhammarHenrik Falhammar
Henrik Falhammar
KBKerstin Brismar
Kerstin Brismar
Harvest F. GuHarvest F. Gu
Harvest F. Gu
Diabetic kidney disease (DKD) is a complex disease, in which local inflammatory stress results from both metabolic and hemodynamic derangements. Intercellular adhesion molecule 1 (ICAM-1) is an acute-phase protein marker of inflammation. In the recent years, clinical observations have reported that increased serum/plasma ICAM-1 levels are positively correlated with albuminuria in the patients with type 1 (T1D) and type 2 diabetes (T2D). Genetic association studies have demonstrated that genetic polymorphisms, including SNP rs5498 (E469K, G/A), in theICAM1gene is associated with DKD. rs5498 is a nonsynonymous SNP and caused by substitution between E (Glu) and K (Lys) for ICAM-1 protein. In this review, we first summarized the genetic effects ofICAM1E469K polymorphism in DKD and then demonstrated the possible changes of ICAM-1 protein crystal structures according to the genotypes of this polymorphism. Finally, we discussed the genetic effects of theICAM1E469K polymorphism and the biological role of increased circulating ICAM-1 protein and its formation changes in DKD.

1 January 2019
Verified
Journal Article
Closed access
XZXiuli Zhang
Xiuli Zhang
TGTingwen Guan
Tingwen Guan
BYBoxuan Yang
Boxuan Yang
ZCZhihong Chi
Zhihong Chi
QWQijun Wan
Qijun Wan
Harvest F. GuHarvest F. Gu
Harvest F. Gu

23 July 2022 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
YCYinmao Chi
Yinmao Chi
XZXiuli Zhang
Xiuli Zhang
DLDan Liang
Dan Liang
YWYue Wang
Yue Wang
XCXiaoyi Cai
Xiaoyi Cai
ZCZhi-Hong Chi
Zhi-Hong Chi